An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
Pulmonary arterial hypertension is a progressive fatal disease characterized by pathological pulmonary artery remodeling. Here the authors show that the dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in the endothelium is involved in the progression of pulmonary hyper...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/728f1b45db854296bbbfe58a3c54de8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:728f1b45db854296bbbfe58a3c54de8f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:728f1b45db854296bbbfe58a3c54de8f2021-12-02T11:39:46ZAn endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension10.1038/s41467-021-21961-32041-1723https://doaj.org/article/728f1b45db854296bbbfe58a3c54de8f2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21961-3https://doaj.org/toc/2041-1723Pulmonary arterial hypertension is a progressive fatal disease characterized by pathological pulmonary artery remodeling. Here the authors show that the dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in the endothelium is involved in the progression of pulmonary hypertension.Gusty R. T. RyantoKoji IkedaKazuya MiyagawaLy TuChristophe GuignabertMarc HumbertTomoyuki FujiyamaMasashi YanagisawaKen-ichi HirataNoriaki EmotoNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Gusty R. T. Ryanto Koji Ikeda Kazuya Miyagawa Ly Tu Christophe Guignabert Marc Humbert Tomoyuki Fujiyama Masashi Yanagisawa Ken-ichi Hirata Noriaki Emoto An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
description |
Pulmonary arterial hypertension is a progressive fatal disease characterized by pathological pulmonary artery remodeling. Here the authors show that the dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in the endothelium is involved in the progression of pulmonary hypertension. |
format |
article |
author |
Gusty R. T. Ryanto Koji Ikeda Kazuya Miyagawa Ly Tu Christophe Guignabert Marc Humbert Tomoyuki Fujiyama Masashi Yanagisawa Ken-ichi Hirata Noriaki Emoto |
author_facet |
Gusty R. T. Ryanto Koji Ikeda Kazuya Miyagawa Ly Tu Christophe Guignabert Marc Humbert Tomoyuki Fujiyama Masashi Yanagisawa Ken-ichi Hirata Noriaki Emoto |
author_sort |
Gusty R. T. Ryanto |
title |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
title_short |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
title_full |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
title_fullStr |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
title_full_unstemmed |
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
title_sort |
endothelial activin a-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/728f1b45db854296bbbfe58a3c54de8f |
work_keys_str_mv |
AT gustyrtryanto anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kojiikeda anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kazuyamiyagawa anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT lytu anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT christopheguignabert anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT marchumbert anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT tomoyukifujiyama anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT masashiyanagisawa anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kenichihirata anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT noriakiemoto anendothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT gustyrtryanto endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kojiikeda endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kazuyamiyagawa endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT lytu endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT christopheguignabert endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT marchumbert endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT tomoyukifujiyama endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT masashiyanagisawa endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT kenichihirata endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension AT noriakiemoto endothelialactivinabonemorphogeneticproteinreceptortype2linkisoverdriveninpulmonaryhypertension |
_version_ |
1718395706060832768 |